News

Transforming Digital Commerce: ABB Robotics Partners with Coveo

Transforming Digital Commerce: ABB Robotics Partners with Coveo

Innovative Partnership to Boost Customer Experience

ABB Robotics, a leader in the robotics sector, has made a significant decision to enhance its customer interaction through technology. They've partnered with Coveo, an industry frontrunner in AI-relevance, to transform how users engage with their products and services on the Robotics One Customer Portal. This collaboration aims to leverage AI technologies to create a more personalized and effective digital experience.

Enhancing Product Discovery with AI

The integration of Coveo's cutting-edge AI solutions into the Robotics One Customer Portal means that customers will now benefit from a seamless product discovery process. Whether seeking technical information, quotes, or solutions, users will find it easier to navigate and utilize ABB's offerings. With AI-enhanced search capabilities, the portal will guide users from a variety of solutions, including robotics, software, and services, all backed by pertinent content such as datasheets and product manuals.

Customer Empowerment through Technology

As more features roll out, the portal will not only assist end-users but also empower system integrators and sales representatives by enabling rapid quote generation and delivering critical technical insights. This evolution in the customer journey is expected to decrease the number of support inquiries and enhance self-service capabilities, making every interaction more efficient and meaningful. ABB aims to provide unmatched value for its customers through this digital transformation.

Future-Proofing the Digital Commerce Experience

Marina Bill, the global head of marketing and sales and product line digital and software within the Robotics Division at ABB, expressed enthusiasm about the partnership. "By leveraging Coveo's AI-Relevance, we are future-proofing our digital commerce experience—creating a smarter, more efficient, and highly personalized journey for our customers, sales teams, and partners," she stated. The integration of Coveo's technology is expected to transform ABB’s digital landscape, giving it a competitive advantage in the market.

AI-Powered Solutions for Enhanced Customer Engagement

Coveo is renowned for its advanced AI capabilities that aid businesses in maximizing their potential. Their recognition as a Leader in the Gartner Magic Quadrant for Search and Product Discovery underscores their authority in the sector. This partnership signifies a commitment to scalability and efficiency, optimizing the buying experience through AI-driven search, recommendations, and personalized content delivery.

Optimizing the Buying Experience

By utilizing Coveo AI for Commerce, ABB Robotics will enhance its platform, introducing functionalities that address complex pricing mechanisms and entitlements. Customers will benefit from real-time visibility to ensure they receive the right products at the right price. This not only simplifies the buying process but also ensures buyers are connected to relevant content to facilitate informed decisions.

Driving Value Through Data and Insights

With the integration of Coveo, ABB has the opportunity to maximize return on investment by utilizing data-driven insights to make strategic business decisions. Reports indicate Coveo's ability to increase average order value and search engagement, further proving that such technological implementations are not just advantageous but essential for modern commerce.

Commitment to Continuous Improvement

The ambitions of this partnership align closely with Coveo's mission to drive continuous improvement for its clients. Peter Curran, GM of Commerce at Coveo, expressed excitement about the collaboration. "Together, we're creating a smarter, more efficient, and highly personalized digital commerce experience." This sentiment underscores the belief that innovative digital solutions can radically transform customer engagement and experience.

As this partnership develops, it promises to set a new standard for customer interaction in the robotics industry, paving the way for further advancements in digital commerce.

Frequently Asked Questions

What is the main goal of the partnership between ABB Robotics and Coveo?

The primary aim is to enhance product discovery and customer experience through advanced AI solutions integrated into the Robotics One Customer Portal.

How will the Robotics One Customer Portal benefit users?

It will provide a unified digital journey, allowing customers to easily access technical information, configure solutions, and place orders with intuitive navigation driven by AI.

What features will Coveo bring to ABB Robotics' platform?

Coveo will introduce AI-powered search, recommendations, and personalized merchandising to optimize the user experience significantly.

Who can use the Robotics One Customer Portal?

The portal is designed for a variety of users, including end customers, system integrators, and sales representatives, streamlining their interactions with ABB’s offerings.

What does the future hold for this partnership?

The collaboration aims to continuously enhance the digital experience, leveraging AI to provide even more personalized and efficient services to ABB's customer base.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading